Allain H., Bentue-Ferrer D., Vellas B., Gauthier S. (2006). Pharmacothérapeutique des démences sévères, L’Année Gérontologique, 20, Serdi, Paris, 84-91.

Belleville S., Gilbert B., Fontaine F., Gagnon L., Menard E., Gauthier S. (2006). Improvement of Episodic Memory in Persons with Mild Cognitive Impairment and Healthy Older Adults: Evidence from a Cognitive Intervention Program, Dement Geriatr Cogn Disord, 22(5-6), 486-499.

Feldman H. H., Gauthier S., Chertkow H., Conn D. K., Freedman M., Chris M. (2006). Progress in clinical neurosciences: Canadian guidelines for the development of antidementia therapies: a conceptual summary, Can J Neurol Sci, 33(1), 6-26.

Ferreri F., Agbokou C., Gauthier S. (2006). Cognitive dysfunctions in schizophrenia: potential benefits of cholinesterase inhibitor adjunctive therapy., J Psychiatry Neurosci, 31, 369-376.

Ferreri F., Agbokou C., Gauthier S. (2006). Recognition and management of neuropsychiatric complications in Parkinson's disease, Cmaj, 175(12), 1545-52.

Gagnon J. F., Petit D., Fantini M. L., Rompre S., Gauthier S., Panisset M., Robillard A., Montplaisir J. (2006). REM sleep behavior disorder and REM sleep without atonia in probable Alzheimer disease, Sleep, 29(10), 1321-5.

Gauthier S. (2006). Treatment success in Alzheimer’s Disease, J Nutrition Health & Aging, 10, 242.

Gauthier S. (2006). Delirium and dementia in the elderly . In Calhoun K. H. & Eibling D. E. (Eds.) , Geriatric Otolaryngology (pp. 603-608). Taylor & Francis.

Gauthier S. (2006). Clinical features of severe dementia: function . In Burns A. & Winblad B. (Eds.) , Severe Dementia (pp. 117-121). John Wiley & Sons, Ltd..

Gauthier S. (2006). Alzheimer's disease . In Schulz R., Noelker L., Rockwood K., Sprott R. & Schulz R. (Eds.) , The Encyclopedia of Aging (pp. 54-54). Springer Publishing Company.

Gauthier S. (2006). Commentary on Mild Cognitive Impairment, Int Psychogeriatr, 18, 409-410.

Gauthier S. (2006). Cholinesterase inhibitors in late-stage Alzheimer's disease, Lancet Neurol, 5(6), 468-9.

Gauthier S. (2006). Managing discontinuation syndrome in patients with dementia, J Psychiatry Neurosci, 31(1), 72.

Gauthier S. (2006). Les traitements par les inhibiteurs des cholinesterases, L’Année Gérontologique, 20, Serdi, Paris, 382-385.

Gauthier S. (2006). Current and future therapies for Alzheimer's disease and related disorders, Future Neurol, 1, 741-745.

Gauthier S., Herrmann N., Ferreri F., Agbokou C. (2006). Use of memantine to treat Alzheimer's disease, Cmaj, 175(5), 501-2.

Gauthier S., Joober R., Dube M. P., St-Onge J., Bonnel A., Gariepy D., Laurent S., Najafee R., Lacasse H., St-Charles L., Fombonne E., Mottron L., Rouleau G. A. (2006). Autism spectrum disorders associated with X chromosome markers in French-Canadian males, Mol Psychiatry, 11(2), 206-13.

Gauthier S., Juby A., Morelli L., Rehel B., Schecter R. (2006). A large, naturalistic, community-based study of rivastigmine in mild-to-moderate AD: the EXTEND Study, Curr Med Res Opin, 22(11), 2251-65.

Gauthier S., Reisberg B., Zaudig M., Petersen R. C., Ritchie K., Broich K., Belleville S., Brodaty H., Bennett D., Chertkow H., Cummings J. L., de Leon M., Feldman H., Ganguli M., Hampel H., Scheltens P., Tierney M. C., Whitehouse P., Winblad B. (2006). Mild cognitive impairment, Lancet, 367(9518), 1262-70.

Gauthier S., Vellas B., Farlow M., Burn D. (2006). Aggressive course of disease in dementia, Alzheimers Dement, 2, 210-217.